Literature DB >> 12414768

Patterns of cytokines and soluble cellular receptors in the sera of children with acute chagas' disease.

Edgardo Moretti1, Beatriz Basso, Liliana Cervetta, Ana Brigada, Gustavo Barbieri.   

Abstract

Cytokines and soluble cellular receptors are involved in inflammatory processes and probably in the pathogenesis of parasite and bacterial diseases. In a previous study, we reported increased levels of soluble receptors of interleukin-2 (sIL2-R) in children with acute Chagas' disease, one of the main parasitic infections that is endemic in Latin America. We sought to analyze the pattern of different cytokines and soluble receptors in the sera of children with chagasic infection. Children with acute and indeterminate stages of Chagas' disease, as well as nonchagasic children, were studied. Sera were assayed by enzyme-linked immunosorbent assay to measure the levels of tumor necrosis factor alpha (TNF-alpha), IL-6, IL-2, IL-8, IL-12, sIL-2R, and the soluble receptors of CD8 and CD4 (sCD8 and sCD4). sIL-2R and sCD8 showed the highest levels in serum in acutely infected children, decreasing after specific antiparasite therapy. Chronic children showed a pattern similar to the one of nonchagasic children. Although they were not statistically significant, TNF-alpha, IL-6, and sCD4 showed a tendency to reach high levels in the acutely infected group, whereas IL-2, IL-8, and IL-12 did not reveal changes with respect to the noninfected children. In summary, we report here the patterns of cytokines and soluble receptors in in the sera of children infected with Trypanosoma cruzi; we found significantly increased levels of sIL-2R and sCD8 in acute infection that decreased after therapy, and high levels of TNF-alpha, IL-6, and sCD4 in some of the acute patients. The measurement of sIL-2R and sCD8 may provide a useful tool in the follow-up of children with Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414768      PMCID: PMC130093          DOI: 10.1128/cdli.9.6.1324-1327.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

1.  Serum cytokines in chronic Chagas' disease.

Authors:  L S Ward; M E Guariento; G A Fernandes; R M Maciel
Journal:  Rev Soc Bras Med Trop       Date:  1999 May-Jun       Impact factor: 1.581

2.  The haematocrit centrifuge for the detection of trypanosomes in blood.

Authors:  P T Woo
Journal:  Can J Zool       Date:  1969-09       Impact factor: 1.597

3.  [Treatment of Chagas' disease with nifurtimox during the first months of life].

Authors:  P R Moya; R D Paolasso; S Blanco; M Lapasset; C Sanmartino; B Basso; E Moretti; D Cura
Journal:  Medicina (B Aires)       Date:  1985       Impact factor: 0.653

4.  Cytokine serum level during severe sepsis in human IL-6 as a marker of severity.

Authors:  P Damas; D Ledoux; M Nys; Y Vrindts; D De Groote; P Franchimont; M Lamy
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

5.  Correlation of plasma cytokine elevations with mortality rate in children with sepsis.

Authors:  J S Sullivan; L Kilpatrick; A T Costarino; S C Lee; M C Harris
Journal:  J Pediatr       Date:  1992-04       Impact factor: 4.406

6.  [Neonatal Chagas disease: laboratory diagnosis during the first year of life].

Authors:  P Moya; E Moretti; R Paolasso; B Basso; S Blanco; C Sanmartino; A Soich de Cura
Journal:  Medicina (B Aires)       Date:  1989       Impact factor: 0.653

7.  Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.

Authors:  E Girardin; G E Grau; J M Dayer; P Roux-Lombard; P H Lambert
Journal:  N Engl J Med       Date:  1988-08-18       Impact factor: 91.245

8.  Serum tumor necrosis factor levels in patients with infectious disease and septic shock.

Authors:  F Offner; J Philippé; D Vogelaers; F Colardyn; G Baele; M Baudrihaye; A Vermeulen; G Leroux-Roels
Journal:  J Lab Clin Med       Date:  1990-07

9.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

10.  Trypanosoma cruzi induces suppression of DNA synthesis and inhibits expression of interleukin-2 receptors by stimulated human B lymphocytes.

Authors:  F Kierszenbaum; E Moretti; M B Sztein
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

View more
  14 in total

1.  Trypanosoma cruzi: experimental parasitism of bone and cartilage.

Authors:  Antonio Morocoima; Marlene Rodríguez; Leidi Herrera; Servio Urdaneta-Morales
Journal:  Parasitol Res       Date:  2006-05-24       Impact factor: 2.289

Review 2.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 3.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

4.  Effects of blood sample age at time of separation on measured cytokine concentrations in human plasma.

Authors:  Rachael P Jackman; Garth H Utter; John W Heitman; Dale F Hirschkorn; Jacqueline P Law; Nelly Gefter; Michael P Busch; Philip J Norris
Journal:  Clin Vaccine Immunol       Date:  2010-12-15

Review 5.  Modulation of immune response in experimental Chagas disease.

Authors:  Beatriz Basso
Journal:  World J Exp Med       Date:  2013-02-20

Review 6.  Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy.

Authors:  Ludmila Rodrigues Pinto Ferreira; Amanda Farage Frade; Monique Andrade Baron; Isabela Cunha Navarro; Jorge Kalil; Christophe Chevillard; Edecio Cunha-Neto
Journal:  World J Cardiol       Date:  2014-08-26

Review 7.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

8.  Benzonidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children.

Authors:  Romina A Cutrullis; Guillermo F Moscatelli; Samanta Moroni; Bibiana J Volta; Rita L Cardoni; Jaime M Altcheh; Ricardo S Corral; Héctor L Freilij; Patricia B Petray
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

9.  Alterations to the Cardiac Metabolome Induced by Chronic T. cruzi Infection Relate to the Degree of Cardiac Pathology.

Authors:  Kristyn Hoffman; Zongyuan Liu; Ekram Hossain; Maria Elena Bottazzi; Peter J Hotez; Kathryn M Jones; Laura-Isobel McCall
Journal:  ACS Infect Dis       Date:  2021-04-12       Impact factor: 5.578

Review 10.  The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi Infection.

Authors:  Carlos Gustavo Vieira de Morais; Ana Karina Castro Lima; Rodrigo Terra; Rosiane Freire dos Santos; Silvia Amaral Gonçalves Da-Silva; Patrícia Maria Lourenço Dutra
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.